JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Photodermatit developed with pirfenidone treatment in patient diagnosed with IPF
Abstract
Idiopathic pulmonary fibrosis (IPF) is the most common of the major idiopathic interstitial pneumonia (IIP) of unknown etiology, often presenting in advanced age, limited to the lungs, characterized by histopathologically and/or radiologically usual interstitial pneumonia (UIP) pattern, and progressing with chronic, progressive fibrosis. is the most common form. Since IPF is a disease with irreversible fibrosis, there is no curative treatment except lung transplantation. The aim of the treatments given is to stop the progression of the disease, to prevent exacerbations and to prolong the survival time. The greatest improvement in the treatment of IPF in recent years has been the use of antifibrotic drugs (Pirfenidone and nintedanib) that prevent fibrosis developing in the lung parenchyma. In this case, we aimed to present the side effect of photodermatitis in a patient who applied to our outpatient clinic with complaints of shortness of breath and cough for many years and was diagnosed with IPF and started on pirfenidone treatment.

Keywords : Pirfenidone, photosensitivity reaction, idiopathic pulmonary fibrosis

Download Article


1. Kırkıl G. İdiyopatik pulmoner Fibrozis. In: Karadağ M., Kaya A.,Özlü T., Göğüs Hastalıkları Tanı ve Tedavi El Kitabı, 1st ed. BilimselTıp;2022:415-419.
2. Akıncı Özyürek B.Bölüm 6. İdiyopatik pulmoner Fibrozis. In: Akıncı Özyürek B. İnterstisyel Akciğer HastalıklarınaGüncel Yaklaşım, 1st ed. MediHealth Academy;2022:101-188
3. Idiopathic pulmonary Fibrosis (IPF) and Progressive pulmonaryFibrosis (PPF) Diagnosis and Treatment Consensus Report, TurkishThoracic Society, 2023. (https://toraks.org.tr/site/sf/s/2023/06/4ec31577de1525b2813c6ae02a3a901156d8b99969ad1023713180b08622bc65.pdf)
4. Wu W, Qiu L, Wu J, Liu X, Zhang G. Efficacy and safety of pirfenidonein the treatment of idiopathic pulmonary fibrosis patients: a systematicreview and meta-analysis of randomised controlled trials. BMJOpen. 2021;11(12):e050004. Published 2021 Dec 31. doi:10.1136/bmjopen-2021-050004
5. Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathicpulmonary fibrosis with a new antifibrotic agent, pirfenidone: resultsof a prospective, open-label Phase II study. Am J Respir Crit Care Med.1999;159(4 Pt 1):1061-1069. doi:10.1164/ajrccm.159.4.9805017
6. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlledtrial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am JRespir Crit Care Med. 2005;171(9):1040-1047. doi:10.1164/rccm.200404-571OC
7. Duyar SŞ.Bölüm 14. İnterstisyel akciğer hastalıklarında farmakolojiktedavi. In: Akıncı Özyürek B. İnterstisyel Akciğer HastalıklarınaGüncel Yaklaşım, 1st ed. MediHealth Academy;2022:381-388.
8. Yaşar Z, Çetinkaya E. İdiopatik pulmoner fibroziste güncel tedaviyaklaşımı [Current management of idiopathic pulmonary fibrosis].Tuberk Toraks. 2015;63(4):278-290. doi:10.5578/tt.9181
9. Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients withidiopathic pulmonary fibrosis (CAPACITY): two randomised trials.Lancet. 2011;377(9779):1760-1769. doi:10.1016/S0140-6736(11)60405-4
Article available in :
Volume 1, Issue 3, 2023
Page : 76-78
https://doi.org/10.51271/JOPIC-0018
Article Information
Received : 01 Ağu 2023
Accepted : 22 Ağu 2023
Published : 29 Ağu 2023
Corresponding Author :

Deniz Çelik: Department of Chest Diseases, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkiye

[email protected]
Citation : Akkuş E, Çelik D, Yetkin Ö, Lakadamyalı H. Photodermatit developed withpirfenidonetreatment in patient diagnosed with IPF. J Pulmonol Intens Care. 2023; 1(3): 76-78

Read: 701
Download : 479
Cited: 1
_Footer